vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and i3 Verticals, Inc. (IIIV). Click either name above to swap in a different company.

Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $52.7M, roughly 1.4× i3 Verticals, Inc.). On growth, Fulgent Genetics, Inc. posted the faster year-over-year revenue change (-3.2% vs -14.6%). Over the past eight quarters, Fulgent Genetics, Inc.'s revenue compounded faster (0.1% CAGR vs -4.7%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

The Prusa i3 is a family of fused filament fabrication 3D printers, manufactured by Czech company Prusa Research under the trademarked name Original Prusa i3. Part of the RepRap project, Prusa i3 printers were called the most used 3D printer in the world in 2016. The first Prusa i3 was designed by Josef Průša in 2012, and was released as a commercial kit product in 2015. The latest model is available in both kit and factory assembled versions. The Prusa i3's comparable low cost and ease of co...

FLGT vs IIIV — Head-to-Head

Bigger by revenue
FLGT
FLGT
1.4× larger
FLGT
$71.1M
$52.7M
IIIV
Growing faster (revenue YoY)
FLGT
FLGT
+11.5% gap
FLGT
-3.2%
-14.6%
IIIV
Faster 2-yr revenue CAGR
FLGT
FLGT
Annualised
FLGT
0.1%
-4.7%
IIIV

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FLGT
FLGT
IIIV
IIIV
Revenue
$71.1M
$52.7M
Net Profit
$484.0K
Gross Margin
30.2%
Operating Margin
21.1%
3.1%
Net Margin
0.9%
Revenue YoY
-3.2%
-14.6%
Net Profit YoY
-76.5%
EPS (diluted)
$0.04
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
IIIV
IIIV
Q1 26
$71.1M
Q4 25
$83.3M
$52.7M
Q3 25
$84.1M
$46.0M
Q2 25
$81.8M
$51.9M
Q1 25
$73.5M
$63.1M
Q4 24
$76.2M
$52.2M
Q3 24
$71.7M
$32.0M
Q2 24
$71.0M
$46.2M
Net Profit
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
$-23.4M
$484.0K
Q3 25
$-6.6M
$3.1M
Q2 25
$-19.0M
$12.9M
Q1 25
$-11.5M
$-154.0K
Q4 24
$-5.9M
$2.1M
Q3 24
$-14.6M
$117.9M
Q2 24
$-8.7M
$-7.5M
Gross Margin
FLGT
FLGT
IIIV
IIIV
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
IIIV
IIIV
Q1 26
21.1%
Q4 25
-43.5%
3.1%
Q3 25
-18.3%
3.2%
Q2 25
-24.1%
-9.3%
Q1 25
-26.9%
8.0%
Q4 24
-21.2%
3.9%
Q3 24
-23.8%
10.6%
Q2 24
-26.6%
-2.8%
Net Margin
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
-28.1%
0.9%
Q3 25
-7.9%
6.7%
Q2 25
-23.2%
24.8%
Q1 25
-15.7%
-0.2%
Q4 24
-7.7%
3.9%
Q3 24
-20.4%
368.2%
Q2 24
-12.3%
-16.3%
EPS (diluted)
FLGT
FLGT
IIIV
IIIV
Q1 26
$0.04
Q4 25
$0.02
Q3 25
$0.14
Q2 25
$0.50
Q1 25
$0.00
Q4 24
$0.08
Q3 24
$4.93
Q2 24
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
IIIV
IIIV
Cash + ST InvestmentsLiquidity on hand
$23.4M
$37.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$358.5M
Total Assets
$1.2B
$595.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
IIIV
IIIV
Q1 26
$23.4M
Q4 25
$50.2M
$37.5M
Q3 25
$117.6M
$66.7M
Q2 25
$87.9M
$55.5M
Q1 25
$67.3M
$7.7M
Q4 24
$55.1M
$85.6M
Q3 24
$58.0M
$86.5M
Q2 24
$65.1M
$9.7M
Total Debt
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
Q3 25
$0
Q2 25
$0
Q1 25
$12.0M
Q4 24
$26.2M
Q3 24
$26.2M
Q2 24
$374.1M
Stockholders' Equity
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
$1.1B
$358.5M
Q3 25
$1.1B
$389.6M
Q2 25
$1.1B
$383.3M
Q1 25
$1.1B
$385.2M
Q4 24
$1.1B
$375.0M
Q3 24
$1.1B
$379.7M
Q2 24
$1.1B
$249.7M
Total Assets
FLGT
FLGT
IIIV
IIIV
Q1 26
$1.2B
Q4 25
$1.2B
$595.9M
Q3 25
$1.2B
$638.4M
Q2 25
$1.2B
$623.3M
Q1 25
$1.2B
$646.4M
Q4 24
$1.2B
$726.2M
Q3 24
$1.2B
$730.7M
Q2 24
$1.2B
$861.7M
Debt / Equity
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.03×
Q4 24
0.07×
Q3 24
0.07×
Q2 24
1.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLGT
FLGT
IIIV
IIIV
Operating Cash FlowLast quarter
$14.1M
Free Cash FlowOCF − Capex
$13.8M
FCF MarginFCF / Revenue
26.2%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
29.18×
TTM Free Cash FlowTrailing 4 quarters
$6.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
$-78.1M
$14.1M
Q3 25
$11.1M
$14.0M
Q2 25
$-30.2M
$7.4M
Q1 25
$-4.4M
$-27.1M
Q4 24
$25.0M
$11.5M
Q3 24
$-15.5M
$15.1M
Q2 24
$4.3M
$8.1M
Free Cash Flow
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
$-83.1M
$13.8M
Q3 25
$5.1M
$13.5M
Q2 25
$-37.0M
$6.8M
Q1 25
$-9.1M
$-27.6M
Q4 24
$21.2M
$11.0M
Q3 24
$-35.0M
$14.6M
Q2 24
$-8.7M
$7.2M
FCF Margin
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
-99.7%
26.2%
Q3 25
6.0%
29.5%
Q2 25
-45.2%
13.1%
Q1 25
-12.5%
-43.8%
Q4 24
27.9%
21.1%
Q3 24
-48.8%
45.6%
Q2 24
-12.2%
15.6%
Capex Intensity
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
6.0%
0.6%
Q3 25
7.2%
0.9%
Q2 25
8.3%
1.0%
Q1 25
6.4%
0.8%
Q4 24
5.0%
0.9%
Q3 24
27.2%
1.7%
Q2 24
18.2%
1.9%
Cash Conversion
FLGT
FLGT
IIIV
IIIV
Q1 26
Q4 25
29.18×
Q3 25
4.52×
Q2 25
0.57×
Q1 25
Q4 24
5.59×
Q3 24
0.13×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLGT
FLGT

Segment breakdown not available.

IIIV
IIIV

License And Service$35.7M68%
Proprietary Payments Revenue$14.5M27%
Other Revenue$2.5M5%

Related Comparisons